Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/14/2003CA2385777A1 Use of anti-tnf.alpha.antibodies and another drug
10/14/2003CA2367107C Methods for limiting scar and adhesion formation
10/14/2003CA2340221C Injectable formulations of nanoparticulate naproxen
10/14/2003CA2317019C Magnetically responsive composition
10/14/2003CA2291994C Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
10/14/2003CA2288376C Syndecan interacting proteins and the use thereof
10/14/2003CA2286750C Application and production process of a group of anticancer compounds
10/14/2003CA2271865C Tablet composition
10/14/2003CA2225601C New stable pharmaceutical preparation for producing propellant-free aerosols
10/14/2003CA2205509C Microbicidal triazolyl derivatives
10/14/2003CA2184747C Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors
10/14/2003CA2122911C 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/14/2003CA2114838C A process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
10/14/2003CA2109424C Anti-free-radical topical composition based on a superoxide-dismutase and a phosphonic derivative
10/14/2003CA2082740C Controlled release device
10/14/2003CA2040001C Hypoallergenic wheat preparation, process for producing the same, and processed food including the same
10/09/2003WO2003083442A2 Life sciences business systems and methods
10/09/2003WO2003083139A1 Method of examining allergic disease
10/09/2003WO2003083135A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
10/09/2003WO2003083113A2 Growth regulating proteins
10/09/2003WO2003083110A1 Novel galactose transferases, peptides thereof and nucleic acid encoding the same
10/09/2003WO2003083068A2 Compounds and methods
10/09/2003WO2003083067A2 Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease
10/09/2003WO2003083058A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/09/2003WO2003083057A2 Adipocytes and uses thereof
10/09/2003WO2003083050A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082893A2 Theraputic methods and uses of sapogenins and their derivatives
10/09/2003WO2003082878A1 Substituted amino isoxazoline derivatives and their use as anti-depressants.
10/09/2003WO2003082877A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/09/2003WO2003082876A1 4-beta-1''-`(2''-(substituted benzoyl)anilino! podophyllotoxin analogues useful as anticancer agents
10/09/2003WO2003082874A2 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
10/09/2003WO2003082873A1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives
10/09/2003WO2003082872A1 Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/09/2003WO2003082870A1 Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone
10/09/2003WO2003082869A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003WO2003082868A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003WO2003082867A1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
10/09/2003WO2003082866A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/09/2003WO2003082865A1 Medicinal antitumor composition
10/09/2003WO2003082864A2 Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
10/09/2003WO2003082863A1 N-(morpholin-2yl) methyl acetamide derivatives as ccr-3 antagonists useful in the treatment of inflammatory diseases
10/09/2003WO2003082862A1 Anti-inflammatory morpholin-acetamide derivatives
10/09/2003WO2003082861A2 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
10/09/2003WO2003082859A1 Indolylmaleimide derivatives
10/09/2003WO2003082858A1 Crystalline forms of rabeprazole sodium
10/09/2003WO2003082857A2 Lansoprazole polymorphs and processes for preparation thereof
10/09/2003WO2003082856A1 Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists
10/09/2003WO2003082855A1 Anti-inflammatory agent
10/09/2003WO2003082853A1 New compounds
10/09/2003WO2003082852A1 Novel substituted 1,2,4-trioxanes useful as antimalarial agents and a process for the preparation thereof
10/09/2003WO2003082848A1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
10/09/2003WO2003082845A1 Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same
10/09/2003WO2003082842A1 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
10/09/2003WO2003082841A1 5-substituted 1,1-dioxo-`1,2,5!thiazolidine-3-one derivatives as ptpase 1b inhibitors
10/09/2003WO2003082840A1 κ-OPIOID RECEPTOR AGONIST COMPRISING 2-PHENYLBENZOTHIAZOLINE DERIVATIVE
10/09/2003WO2003082839A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003WO2003082837A1 Hydroxymorpholinone derivative and medicinal use thereof
10/09/2003WO2003082833A1 1,2,4-triazole derivatives with cannabinoid properties
10/09/2003WO2003082832A2 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003WO2003082831A1 4-anilino quinazoline derivatives as antiproliferative agents
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082828A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/09/2003WO2003082827A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
10/09/2003WO2003082825A1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
10/09/2003WO2003082820A1 (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative
10/09/2003WO2003082818A1 Alkaloids compounds, analgesic pharmaceuticals and their preparation
10/09/2003WO2003082817A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003WO2003082814A1 Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization
10/09/2003WO2003082813A2 Improvements in pharmaceutical compositions
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082807A2 Amino acids with affinity for the alpha-2-delta-protein
10/09/2003WO2003082806A1 Venlafaxine base
10/09/2003WO2003082805A1 Low water-soluble venlafaxine salts
10/09/2003WO2003082804A1 Venlafaxine besylate
10/09/2003WO2003082802A1 Acid and ester compounds and methods of using the same
10/09/2003WO2003082798A1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
10/09/2003WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082392A2 Oxygenating agents for enhancing host responses to microbial infections
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082349A1 Treatment methods for eotaxin mediated inflammatory conditions
10/09/2003WO2003082348A1 Nanogel networks including polyion polymer fragments and biological agent compositions thereof
10/09/2003WO2003082347A1 Diagnostic for diseases associated with cerebrospinal fluid circulation failure
10/09/2003WO2003082341A1 AN IMPROVED FORMULATION OF CERTAIN PYRAZOLO[3,4-d] PYRIMIDINES AS KINASE MODULATORS
10/09/2003WO2003082340A1 Injectable veterinary composition for small animals
10/09/2003WO2003082338A1 Remedies for glomerular diseases
10/09/2003WO2003082337A1 Combination comprising a cdk inhibitor and doxorubicin
10/09/2003WO2003082336A1 Female birth control method
10/09/2003WO2003082333A1 Remedy for sleep disturbance
10/09/2003WO2003082332A1 Remedy for glioblastoma
10/09/2003WO2003082331A1 Decoy compositions for treating and preventing brain diseases and disorders
10/09/2003WO2003082323A1 A composition and method for killing of tumours
10/09/2003WO2003082316A1 Microgel particles for the delivery of bioactive materials
10/09/2003WO2003082314A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
10/09/2003WO2003082313A1 Co-beadlet of dha and rosemary and methods of use
10/09/2003WO2003082312A1 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
10/09/2003WO2003082303A1 Polymeric micelle formulations of hydrophobic compounds and methods
10/09/2003WO2003082302A2 Bioadhesive directed somatic cell therapy
10/09/2003WO2003082301A1 Compositions and methods for treating cancer
10/09/2003WO2003082300A1 Use of carbon-2-modified-vitamin d analogs to induce the formation of new bone
1 ... 5313 5314 5315 5316 5317 5318 5319 5320 5321 5322 5323 5324 5325 5326 5327 5328 5329 5330 5331 5332 5333 ... 7860